APA (7th ed.) Citation

MA, B., BT, V., Y, L., R, G., AH, D., D, M., . . . VA, M. (2025). Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: A phase 2 trial. Nature cancer, 6(3), 432. https://doi.org/10.1038/s43018-025-00922-5

Chicago Style (17th ed.) Citation

MA, Bilen, et al. "Neoadjuvant Cabozantinib for Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma: A Phase 2 Trial." Nature Cancer 6, no. 3 (2025): 432. https://doi.org/10.1038/s43018-025-00922-5.

MLA (9th ed.) Citation

MA, Bilen, et al. "Neoadjuvant Cabozantinib for Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma: A Phase 2 Trial." Nature Cancer, vol. 6, no. 3, 2025, p. 432, https://doi.org/10.1038/s43018-025-00922-5.